A detailed history of Burleson & Company, LLC transactions in Viatris Inc stock. As of the latest transaction made, Burleson & Company, LLC holds 428 shares of VTRS stock, worth $5,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
428
Previous 428 -0.0%
Holding current value
$5,354
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022

BUY
$8.48 - $11.13 $203 - $267
24 Added 5.94%
428 $4,000
Q4 2021

Jan 25, 2022

SELL
$12.09 - $14.68 $17,893 - $21,726
-1,480 Reduced 78.56%
404 $5,000
Q3 2021

Nov 02, 2021

SELL
$13.25 - $15.13 $13 - $15
-1 Reduced 0.05%
1,884 $26,000
Q2 2021

Jul 22, 2021

SELL
$12.97 - $16.15 $881 - $1,098
-68 Reduced 3.48%
1,885 $27,000
Q1 2021

May 12, 2021

BUY
$13.59 - $18.54 $26,541 - $36,208
1,953 New
1,953 $27,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.